Gelonghui, January 8th丨Shandong Buchang Pharmaceuticals (603858.SH) announced that in order to improve its strategic development layout, gain market competitive advantages on the basis of segmented management, and promote Business development, it plans to invest in establishing a holding subsidiary, Shandong Buchang Zhenze Pharmaceutical Technology Co., Ltd. (registered according to industrial and commercial registration). To promote a win-win situation for the company and all parties involved, and to create maximum value for the company and its Shareholders, relevant personnel plan to participate in this investment according to the provisions of the "Investment Management Measures for Follow-up Investment Projects of Shandong Buchang Pharmaceuticals Co., Ltd.".